SCHEMBL21787534

SCHEMBL21787534

CC(CO)(CO)NCC(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 1/20 0.36
CHRM1 P11229 1/20 0.36
TBXA2R P21731 1/20 0.36
ADRA1A P35348 1/20 0.36
CTH P32929 1/20 0.36
TSHR P16473 2/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
HIF1A Q16665 1/20 0.35
EGLN1 Q9GZT9 2/20 0.34
TDP1 Q9NUW8 2/20 0.33
ALDH1A1 P00352 2/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
PTGS2 P35354 1/20 0.33
LDHA P00338 1/20 0.33
SRR Q9GZT4 1/20 0.33
FFAR3 O14843 1/20 0.32
NAALAD2 Q9Y3Q0 1/20 0.31
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1982103 0.79 DPP4 (0.44) HMGCRCHRM1TBXA2RADRA1ACTH
SCHEMBL12227731 0.78 EGLN1 (0.41) ADRA1AEGLN1LMNAFFAR3NAALAD2
SCHEMBL4075711 0.77
SCHEMBL2801536 0.77 HMGCR (0.40) HMGCRCHRM1TBXA2RADRA1ACTH
SCHEMBL41886 0.75
SCHEMBL1717828 0.75 HMGCR (0.41) HMGCRCHRM1TBXA2RADRA1ACTH
Hydrochloric Acid SCHEMBL1092821 0.72 HMGCR (0.39) HMGCRCHRM1TBXA2RADRA1ACTH
SCHEMBL42019 0.72 LDHA (0.37) CTHEGLN1TDP1ALDH1A1LMNA
Hydrochloric Acid SCHEMBL28883817 0.72 HMGCR (0.39) HMGCRCHRM1TBXA2RADRA1ACTH
Malonic Acid SCHEMBL30288572 0.72 LDHA (0.53) HMGCRCHRM1TBXA2RADRA1ACTH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023045601-A1 METHOD FOR PREPARING TRICINE 苏州亚科科技股份有限公司 2023-03-30 WO disclosed
US-20210246344-A1 Biological buffers with wide buffering ranges DALY THOMAS (US) 2021-08-12 US disclosed
EP-3856257-A1 DEGRADABLE HYALURONIC ACID HYDROGELS Ascendis Pharma A/S (DK) 2021-08-04 EP disclosed
WO-2020064847-A1 DEGRADABLE HYALURONIC ACID HYDROGELS ASCENDIS PHARMA A/S (DK) 2020-04-02 WO disclosed
US-20200071582-A1 Biological Buffers with Wide Buffering Ranges TPAT IP LLC 2020-03-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200071582-A1 Biological Buffers with Wide Buffering Ranges PEF1, SLC7A1, PLPBP HMGCR 4281/4885CHRM1 2714/4885TBXA2R 2430/4885
US-20210246344-A1 Biological buffers with wide buffering ranges PEF1, SLC7A1, PLPBP HMGCR 4264/4885CHRM1 2762/4885TBXA2R 2418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.